NCT06976489View on ClinicalTrials.gov

The Food Effect on PK Characteristics and Safety Profiles of PA-111

PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

40

Participants

Timeline

Start Date

May 31, 2025

Primary Completion Date

July 31, 2025

Study Completion Date

July 31, 2025

Conditions

Mixed Dyslipidemia

Interventions

DRUG

PA-111

PA-111 1Tab., Per Oral

Trial Locations (1)

Unknown

H Plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Addpharma Inc.

INDUSTRY